Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

about

Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

Item

http://www.wikidata.org/entity/Q50540269

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

@en

Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

@nl

type

Item

label

Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

@en

Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

@nl

prefLabel

Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

@en

Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

@nl

P1476

Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

@en

P2093

Caroline E Heughan

http://www.w3.org/2001/XMLSchema#string

Chloe E Ward

http://www.w3.org/2001/XMLSchema#string

Jennifer L MacIsaac

http://www.w3.org/2001/XMLSchema#string

Louis Weatherhead

http://www.w3.org/2001/XMLSchema#string

P2860

NRAS mutation status is an independent prognostic factor in metastatic melanoma.

Final version of 2009 AJCC melanoma staging and classification

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

New developments in sentinel node staging in melanoma: controversies and alternatives.

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.

Sentinel-node biopsy or nodal observation in melanoma.

Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years.

P304

14-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1203475417720201

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28689448

http://www.w3.org/2001/XMLSchema#string